{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:28:19Z","timestamp":1777552099030,"version":"3.51.4"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0102761","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T23:18:22Z","timestamp":1406243902000},"page":"e102761","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Nucleot(s)ide Analogues for Hepatitis B Virus-Related Hepatocellular Carcinoma after Curative Treatment: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Ping","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinggang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qichang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"JF Perz","year":"2006","journal-title":"J Hepatol"},{"key":"ref3","first-page":"244","article-title":"Liver cancer and its prevention","volume":"6","author":"H Tsukuma","year":"2005","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"DM Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"V Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"J Bruix","year":"2005","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2005-871198","article-title":"Resection and liver transplantation for hepatocellular carcinoma","volume":"25","author":"JM Llovet","year":"2005","journal-title":"Semin Liver Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.25937","article-title":"Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy","volume":"57","author":"CL Lai","year":"2013","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"T Hosaka","year":"2013","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1200\/JCO.2012.48.5896","article-title":"Effect of antiviral treatment with nucleotide\/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study","volume":"31","author":"J Yin","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e66457","DOI":"10.1371\/journal.pone.0066457","article-title":"The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy","volume":"8","author":"CW Su","year":"2013","journal-title":"PLoS One"},{"key":"ref12","first-page":"158","article-title":"Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy","volume":"10","author":"Y Ke","year":"2013","journal-title":"Cancer Biol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection","volume":"308","author":"CY Wu","year":"2012","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/S0168-8278(12)61030-7","article-title":"Effect of antiviral therapy on late recurrence after curative resection of B-viral hepatocellular carcinoma (HCC)","volume":"56","author":"JW Lee","year":"2012","journal-title":"Journal of Hepatology"},{"key":"ref15","first-page":"740","article-title":"Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated","volume":"128","author":"HW Hann","year":"2011","journal-title":"International Journal of Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archsurg.2011.125","article-title":"Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma","volume":"146","author":"ACY Chan","year":"2011","journal-title":"Archives of Surgery"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2169\/internalmedicine.48.1534","article-title":"Nucleotide analogs for patients with HBV-related hepatocellular carcinoma increase the survival rate through improved liver function","volume":"48","author":"M Koda","year":"2009","journal-title":"Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00535-009-0093-z","article-title":"The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma","volume":"44","author":"M Chuma","year":"2009","journal-title":"J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12072-007-9020-7","article-title":"Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"2","author":"H Yoshida","year":"2008","journal-title":"Hepatol Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1440-1746.2006.04707.x","article-title":"Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma","volume":"22","author":"T Kuzuya","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1872-034X.2007.00013.x","article-title":"Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus","volume":"37","author":"S Kubo","year":"2007","journal-title":"Hepatol Res"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Nishikawa H, Nishijima N, Arimoto A, Inuzuka T, Kita R, <etal>et al<\/etal>. (2013) Effect of nucleoside analog use in patients with hepatitis B virus-related hepatocellular carcinoma. Hepatol Res.","DOI":"10.1111\/hepr.12169"},{"key":"ref23","unstructured":"Higgins JPT, Green S, editors (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"JF Tierney","year":"2007","journal-title":"Trials"},{"key":"ref25","unstructured":"Wells G, Shea B, O&apos;Connell D, Peterson J, Welch V, <etal>et al<\/etal>.. (2001) The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Ottawa: Ottawa Hospital Research Institute. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\" xlink:type=\"simple\">http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp<\/ext-link>. Accessed 6 July 2014."},{"key":"ref26","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264\u2013269, W264."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1245\/s10434-012-2803-7","article-title":"Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load","volume":"20","author":"G Huang","year":"2013","journal-title":"Annals of Surgical Oncology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00534-011-0489-z","article-title":"Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma","volume":"19","author":"Y Urata","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref29","first-page":"1384A","article-title":"Antiviral therapy after curative resection of hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) improves the outcome in patients with high serum HBV DNA level","volume":"54","author":"E Jeong","year":"2011","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1245\/s10434-009-0694-z","article-title":"A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection","volume":"17","author":"N Li","year":"2010","journal-title":"Annals of Surgical Oncology"},{"key":"ref31","first-page":"52","article-title":"Impact of antiviral therapy on the survival outcome after hepatectomy for hepatitis B-related hepatocellular carcinoma","volume":"12","author":"A Chan","year":"2010","journal-title":"HPB"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1478-3231.2008.01828.x","article-title":"Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"29","author":"JH Kim","year":"2009","journal-title":"Liver Int"},{"key":"ref33","first-page":"249","article-title":"Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection","volume":"53","author":"C Shuqun","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"ref34","first-page":"217","article-title":"Lamivudine treatment in patients with HBV-related hepatocellular carcinoma\u2014using an untreated, matched control cohort","volume":"59","author":"CY Piao","year":"2005","journal-title":"Acta Med Okayama"},{"key":"ref35","first-page":"525A","article-title":"Nucleotide analogues may prolong survival time without recurrence and overall survival time for HBV-related liver diseases after curative treatment of hepatocellular carcinoma","volume":"52","author":"T Inuzuka","year":"2010","journal-title":"Hepatology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1016\/S0168-8278(11)60751-4","article-title":"Clinical implication of hepatitis B viral load in hepatitis B E antigen-negative chronic hepatitis B patients with hepatocellular carcinoma treated with curative resection","volume":"54","author":"JH Shim","year":"2011","journal-title":"Journal of Hepatology"},{"key":"ref37","first-page":"310","article-title":"Effect of hepatitis B viral status on cancer recurrence and long-term prognosis after surgical resection in patients with hepatocellular carcinoma","volume":"4","author":"HJ An","year":"2010","journal-title":"Hepatology International"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s12072-011-9255-1","article-title":"Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation","volume":"5","author":"T Goto","year":"2011","journal-title":"Hepatology International"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1365-2036.2011.04634.x","article-title":"Meta-analysis: The efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma","volume":"33","author":"JSW Wong","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1572-0241.2008.01872.x","article-title":"Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection","volume":"103","author":"IF Hung","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","author":"GV Papatheodoridis","year":"2010","journal-title":"J Hepatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"YF Liaw","year":"2004","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-150-2-200901200-00101","article-title":"Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference","volume":"150","author":"TA Shamliyan","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/SLA.0b013e3182363ff9","article-title":"Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection","volume":"255","author":"LT Chen","year":"2012","journal-title":"Annals of Surgery"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/01.sla.0000245829.00977.45","article-title":"A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma","volume":"245","author":"CM Lo","year":"2007","journal-title":"Annals of Surgery"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00432-006-0091-y","article-title":"Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial","volume":"132","author":"HC Sun","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep.21415","article-title":"Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis","volume":"44","author":"V Mazzaferro","year":"2006","journal-title":"Hepatology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000082098","article-title":"Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma","volume":"48","author":"S Nishiguchi","year":"2005","journal-title":"Intervirology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cncr.20004","article-title":"Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors","volume":"100","author":"SM Lin","year":"2004","journal-title":"Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-138-4-200302180-00008","article-title":"Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus","volume":"138","author":"Y Shiratori","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref51","first-page":"724","article-title":"Interferon therapy for hepatocellular carcinoma patients with low HCV-RNA levels","volume":"49","author":"S Miyaguchi","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/jhep.2000.9409","article-title":"Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus - Related liver cancer","volume":"32","author":"K Ikeda","year":"2000","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Sun P, Yang X, He RQ, Hu QG, Song ZF, <etal>et al<\/etal>.. (2013) Antiviral therapy after curative treatment of hepatitis B\/C virus-related hepatocellular carcinoma: A systematic review of randomized trials. Hepatol Res.","DOI":"10.1111\/hepr.12115"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","journal-title":"J Hepatol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/SLA.0b013e318262b218","article-title":"Posthepatectomy HBV reactivation in hepatitis B-Related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels","volume":"257","author":"G Huang","year":"2013","journal-title":"Annals of Surgery"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jvh.12036","article-title":"Antiviral therapy decreases viral reactivation in patients with hepatitis B virusrelated hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial","volume":"20","author":"L Huang","year":"2013","journal-title":"Journal of Viral Hepatitis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0102761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T05:07:10Z","timestamp":1565672830000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0102761"}},"subtitle":[],"editor":[{"given":"Tetsuo","family":"Takehara","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0102761","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}